| Drug Type Cytokines, Tregs cell therapy | 
| Synonyms Immunotherapeutics(Egle Therapeutics) | 
| Target | 
| Action inhibitors, antagonists | 
| Mechanism CCR8 inhibitor(C-C motif chemokine receptor 8 inhibitors), IL-2R antagonists(Interleukin-2 receptor antagonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Preclinical | France  | 01 Mar 2025 | 






